Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Opioid Consumption, Postoperative × 1 year × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1017 Neoplasms 883 Prostatic Neoplasms 501 Lung Neoplasms 400 Colorectal Neoplasms 336 Motor Activity 212 Head and Neck Neoplasms 187 Uterine Cervical Neoplasms 179 Carcinoma, Non-Small-Cell Lung 168 Brain Neoplasms 166 Pancreatic Neoplasms 157 Colonic Neoplasms 135 Ovarian Neoplasms 133 Carcinoma, Hepatocellular 129 Anxiety Disorders 121 Hematologic Neoplasms 114 Rectal Neoplasms 109 Multiple Myeloma 103 Stomach Neoplasms 101 Neoplasm Metastasis 99 Precursor Cell Lymphoblastic Leukemia-Lymphoma 97 Depression 90 Melanoma 88 Urinary Bladder Neoplasms 87 Pain 87 Endometrial Neoplasms 85 Esophageal Neoplasms 80 Glioblastoma 78 Lymphoma 77 Sarcoma 74

Interventions

Dexmedetomidine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07263165 2025-12-04

Dexmedetomidin

Assiut University

Phase NA Not yet recruiting

Opioid Consumption, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon ⚡